Abortion drug is “essential medicine”, say WHO and The Lancet
An editorial in The Lancet has demanded that chemical abortion drugs be placed on the World Health Organisation’s list of “essential medicines”. More than two months ago, an WHO expert committee recommended this, but it appears that lobbying by the Bush Administration has blocked it. According to the Guardian newspaper, WHO experts feel that chemical abortions are less risky than normal abortions in developing countries, where they can result in serious infections and even death. They acknowledge that the availability of pills might make abortion easier and could increase the number choosing it, but they feel it would reduce the toll of surgical abortions. The Lancet has called upon the WHO to resist American meddling.
The abortion drug, also called RU-486, is highly controversial, especially in the US, although it has been approved in a number of other countries. Because it is self-administered, it is difficult to monitor and it can have serious side-effects, including death.
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...